Genital Warts. Anogenital (venereal) warts
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Confirmation and introduction of a midwifery specialist for the patient to enter the study (having external anogenital warts) Age 18 and up No pregnancy or lactation The desire to participate in research and sign a conscious consent Lack of incurable, metabolic and chronic diseases and weakness in the immune system Do not use corticosteroids or antiviral drugs and weaken the immune system during research Lack of pelvic inflammatory disease, other genital infectious diseases Failure to participate in other research that in any way affects the results of the research Phone access
Exclusion criteria
Exclusion criteria: Lack of proper and appropriate use of drugs Lack of desire to continue research Any allergies caused by the drug Disabling the patient or changing the patient's contact number and not answering the phone call Pregnancy Severe type of disease that requires surgery or systemic medication
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical Signs and Symptoms: In this study, the clinical signs and symptoms of itching, burning, pain, warts and bleeding are considered. Timepoint: Every week and the intervals between visits for a maximum of 12 weeks. Method of measurement: clinical examination, self-report. | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of Life. Timepoint: The day before treatment, after clinical repair. Method of measurement: Life Quality Questionnaire 36 questions SF36. | — |
Countries
Iran (Islamic Republic of)
Contacts
Khoram-Abad University of Medical Sciences